Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark

New Delhi: A Delhi court has permanently restrained a Hyderabad-based pharmaceutical company from using the trademark ‘Udaan’ or any similar mark, ruling that it was a clear violation of the rights of consumer goods major RSPL Health Private Limited, which had earlier registered its mark ‘Udan.’

District Judge Pankaj Sharma, in an ex parte judgment dated August 13, held that the defendant, Sainus Pharmaceutical Private Limited, used the mark ‘Udaan’ in a manner that was “identical and deceptively similar” to the plaintiff’s (RSPL’s) registered trademark ‘Udan’.

The court noted that, according to RSPL Health, known for brands like ‘Ghari’ detergent, it had adopted the trademark or label Udan with respect to the goods and business of sanitary napkins in 2007 and Sainus Pharma’s Udaan mark had infringed its proprietary rights in the said trademark.

“The defendant (Sainus) is not only making the retail sales but is also supplying the impugned goods bearing the impugned trade marks to various other dealers/shopkeepers/retailers in New Delhi, who are making the clandestine and surreptitious sales thereof to the ultimate unwary consumers in the markets of New Delhi viz. Parliament Street, Connaught Place, Barakhamba, Chanakyapuri, Gole Market, Bengali Market etc,” RSPL said.

In its order, the court said that the defendant did not appear before it, and thus the plaintiff’s contentions remain unrebutted, unchallenged, and uncontroverted.

“The plaintiff has established that the defendant has infringed the said trademark and has also committed passing off of goods. Therefore, there is no doubt that the plaintiff is entitled to relief of permanent injunction against the defendant for using the trademark ‘Udaan’ or any other mark identical or deceptively similar to the word mark, label of plaintiff’s trademark Udan,” the court said.

Besides the permanent injunction, the court ordered that all seized counterfeit products and infringing materials, including packaging, dies, and blocks bearing the falsified mark, be delivered to RSPL Health for destruction.

  • Related Posts

    US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

    Lundbeck, a biopharmaceutical company focusing exclusively on brain health, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to asedebart (Lu AG13909), Lundbeck’s novel…

    Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

    Fujifilm India, a leader in advanced diagnostic imaging and healthcare technology, has installed and commissioned the Fujifilm Echelon Smart MRI at Jansons Health in Erode. The installation expands access to…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

    US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

    Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

    Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

    Rajasthan to prepare ‘Narcotics Control Vision 2026-29’ to curb drug abuse and trafficking

    Rajasthan to prepare ‘Narcotics Control Vision 2026-29’ to curb drug abuse and trafficking

    Bracco Imaging expands BubbleGen cell selection with CD3+ T Cell Isolation Kit

    Bracco Imaging expands BubbleGen cell selection with CD3+ T Cell Isolation Kit

    5 medicine samples found substandard in Bhiwadi warehouse raid; probe launched

    5 medicine samples found substandard in Bhiwadi warehouse raid; probe launched

    AiMeD welcomes govt’s offer supporting development of advanced testing infrastructure

    AiMeD welcomes govt’s offer supporting development of advanced testing infrastructure